Warning letter
MedPark Pharmacy, LLC: warning letter of Mar 5, 2018
FDA warning letter 547639 · New Jersey District Office
Key facts
| Reference number | 547639 |
|---|---|
| Company | MedPark Pharmacy, LLC |
| Subject | CGMP/Drug Products/Adulterated |
| Issue date | Mar 5, 2018 |
| Posted date | Mar 13, 2018 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| Inspection city | Annapolis |
| Inspection ZIP | 21401 |
| Inspection start date | Jan 9, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: